Key Insights from the Heart of Pharma: an exclusive CPHI Online report

CPHI Milan, held from October 8–10, 2024 in the historic Fiera Milano, celebrated its 35th edition of bringing together the pharmaceutical industry and supply chain for 3 days of collaborating and innovating. Our first CPHI Wrap-Up Report brings you the latest insight and key takeaways from the Heart of Pharma.
This report dives into 3 days of connecting with pharmaceutical experts, thought leaders, and changemakers. Exclusive interviews with CPHI Milan speakers, deep dives into conference sessions on Manufacturing 5.0, Sustainable Futures, and Next-Gen Bio, emerging pharmaceutical trends from expert roundtables, and observations from the very people who bring CPHI to life are just some of the highlights we bring back from the show floor.
In addition, the CPHI Awards and CPHI Celebration brought two new award categories, the Woman of the Year award and the Future Leader award, to highlight the amazing work of the CPHI team in platforming a diverse body of pharmaceutical professionals.
A keen focus on sustainability and diversity remains a core part of what we do at CPHI, both at our shows and online. This report will bring you unique perspectives on the pharmaceutical industry can put initiatives into action.
At CPHI, we are dedicated to connecting professionals throughout the pharmaceutical supply chain, both at our events and throughout the year with our digital marketing offerings. We are proud to have published four Trend Reports this last year, with two more coming up: the CPHI Middle East Biotech Report and our annual Pharma Trends Outlook for 2025. As we continue to grow and meet the needs of the B2B pharmaceutical sector, we hope that this CPHI Milan Post-Show Report will enable all to understand the biggest trends and conversations happening throughout the pharmaceutical industry today
Download your free Wrap-Up Report here.
Related News
-
News US FDA adds haemodialysis bloodlines to devices shortage list
On March 14, 2025, the US FDA published an open letter to healthcare providers citing continuing supply disruptions of haemodialysis bloodlines, an essential component of dialysis machines. -
News Women in Pharma: Manufacturing personal and team success
Our monthly Women in Pharma series highlights the influential lives and works of impactful women working across the pharmaceutical industry, and how the industry can work towards making the healthcare industry and workplace more equitable and inclusive... -
News Pfizer may shift production back to US under Trump pharma tariffs
At the 45th TD Cowen annual healthcare conference in Boston, USA, Pfizer CEO Albert Bourla outlined the potential for Pfizer to shift its overseas drug manufacturing back to the US as pharmaceutical industry players weigh their options against Presiden... -
News Experimental drug for managing aortic valve stenosis shows promise
The new small molecule drug ataciguat is garnering attention for its potential to manage aortic valve stenosis, which may prevent the need for surgery and significantly improve patient experience. -
News Women in Pharma: Connecting accessible pharma packaging to patients – a Pharmapack Special
Throughout our Women in Pharma series, we aim to highlight how CPHI events encourage discussions around diversity, equity, and inclusion initiatives in the pharmaceutical industry. -
News Vertex Pharmaceuticals stock jumps as FDA approves non-opioid painkiller
UK-based Vertex Pharmaceuticals saw their stock shares soar as the US FDA signed off on the non-opioid painkiller Journavx, also known as suzetrigine, for patients with moderate to severe acute pain, caused by surgery, accidents, or injuries. -
News Trump administration halts global supply of HIV, malaria, tuberculosis drugs
In various memos circulated to the United States Agency for International Development (USAID), the Trump administration has demanded contractors and partners to immediately stop work in supplying lifesaving drugs for HIV, malaria, and tuberculosis to c... -
News 2024 Drug Approvals: a lexicon of notable drugs and clinical trials
50 drugs received FDA approval in 2024. The centre for biologics evaluation and research also identified six new Orphan drug approvals as under Biologics License Applications (BLAs). The following list picks out key approvals from the list, and highlig...
Recently Visited
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance